News | Women's Health | July 21, 2015

North Carolina State University researcher finds celebrity influence had major impact on screening decisions, even above family history

breast cancer screening, Angelina Jolie, Kami Kosenko, North Carolina State

July 21, 2015 Angelina Jolie received widespread media attention in 2013 when she told the public that she'd tested positive for BRCA1, a gene associated with an increased risk of breast and ovarian cancers. Now research shows that this publicity did influence some women's intentions to seek out similar genetic testing.

"We put a questionnaire online within three days of Jolie's announcement, to see if the announcement influenced anyone's intention to get genetic testing," said Kami Kosenko, an associate professor of communication at North Carolina State University and lead author of a paper on the work. "We also wanted to see if there were any variables, such as whether people felt they identified with Jolie, that were associated with people who were influenced by Jolie's announcement."

Three hundred and fifty-six people from across the United States completed the questionnaire, of which 295 were aware of Jolie's announcement and double mastectomy.

Of the 229 female study participants, researchers found that 30 percent intended to get tested to see if they carried the BRCA1 gene, with 23 percent saying they would probably get tested and 7 percent saying they would definitely get tested.

"Women who identified more strongly with Jolie were more likely to intend to get the genetic testing regardless of whether they had a family history of cancer than women who did have a family history of cancer but did not identify with Jolie," Kosenko said. "The same was true of women who felt they had some sort of parasocial relationship with Jolie, meaning they viewed her as a friend. This means that Jolie's speaking out definitely had an impact."

The findings suggest that when it comes to a celebrity's impact on the public, that impact depends in part on the extent to which the public identifies with the celebrity. In other words, there appears to be something about particular celebrities that engenders more public interest and concern.

"This indicates that health practitioners and advocates may want to consider how relatable a celebrity is with the target audience when searching for a celebrity spokesperson," Kosenko said. "However, more work needs to be done to help us understand what makes a celebrity relatable. For example, in our survey, non-white women were more likely to identify with Jolie than white women were. Why is that? We don't know."

The paper, "Celebrity Influence and Identification: A Test of the Angelina Effect," was published online in the Journal of Health Communication.

For more information: www.ncsu.edu


Related Content

News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

April 17, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with the ...

Time April 17, 2024
arrow
News | Mammography

April 16, 2024 — The Radiological Society of North America (RSNA) and GE HealthCare announced their collaboration to ...

Time April 16, 2024
arrow
News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
Videos | Breast Imaging

Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...

Time April 15, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Dose Management

April 11, 2024 — Prelude Corporation (PreludeDx), a leader in precision diagnostics for early-stage breast cancer ...

Time April 11, 2024
arrow
News | Mammography

April 11, 2024 — Volpara Health Technologies Ltd., a global leader in software for the early detection and prevention of ...

Time April 11, 2024
arrow
News | Society of Breast Imaging (SBI)

April 11, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced today ...

Time April 11, 2024
arrow
Subscribe Now